Change provisions relating to the ability of a health care practitioner to provide cross-sex hormones and puberty blockers under the Let Them Grow Act

Brief

What this bill does

If it passes, what actually changes?

This is a state health-law bill. It turns Nebraska's current regulated-permission system for treating minors into a flat ban, and adds a new enforcement tool for the Attorney General.

• New section 71-7305(2)(a) bars practitioners from knowingly prescribing cross-sex hormones or puberty blockers under nineteen.
• That overrides subsection (1), under which the chief medical officer's rules had allowed prescribing after therapy hours, consent, and waiting periods.
• Exempts treatment for congenital defect, precocious puberty, disease, or physical injury; "disease" expressly excludes gender dysphoria.
• New Section 6 lets the Attorney General sue within twenty years to enjoin violations and collect $25,000 per violation.
• Each instance of prescribing or providing is a separate violation; penalties go to the State Treasurer.
• Amends 71-7304 to cover telehealth to a person located in Nebraska, and defines telehealth by section 38-120.01.

What it says it is for

Does it do what it claims?

The title is accurate as far as it goes, but it understates the bill. "Change provisions relating to the ability" describes what reads as a prohibition plus a new penalty scheme.

• Match: sections 3 and 4 do govern practitioners providing cross-sex hormones and puberty blockers under the Let Them Grow Act.
• Divergence: the title says "change provisions"; 71-7305(2)(a) is a ban, not adjusted conditions.
• Divergence: the title omits the Attorney General's new suit power and the $25,000-per-violation penalty in Section 6.
• The bill's purpose clause does disclose Attorney General powers and new definitions; the one-line title does not.
• The title also omits the new "congenital defect" definition, which excludes gender dysphoria and mental conditions.

Where Scripture bears on it

What does the Bible say about this?

The bill's whole architecture rests on a sex fixed at birth — 71-7303(1) defines biological sex by chromosomes, hormones, gonads, and genitalia present at birth, without regard to a person's subjective experience of gender, and every prohibition and carve-out in the act follows from that definition. Scripture's oldest legal material assumes that same binary without arguing for it: "Who shall offer it before the LORD, and make an atonement for her; and she shall be cleansed from the issue of her blood. This is the law for her that hath born a male or a female." (Leviticus 12:7). The bill's second concern is the deliberate interruption of a body's own development — puberty-blocking drugs are defined in 71-7303(10) as drugs used to delay or suppress pubertal development in children — and here a reader may hear "Shall I bring to the birth, and not cause to bring forth? saith the LORD: shall I cause to bring forth, and shut the womb? saith thy God." (Isaiah 66:9), which is an argument that what God begins in a body he means to finish. What neither verse settles is nearly everything the Legislature is actually voting on: they say nothing about medicine, nothing about whether a parent, a physician, or the state decides for a minor, nothing about why the line falls at nineteen rather than eighteen or sixteen, nothing about what a doctor owes a patient two years into treatment on January 2, 2027, and nothing about a twenty-five-thousand-dollar penalty or a twenty-year limitations period. Leviticus 12:7 is a purification law, not a rule for physicians, and Isaiah 66:9 speaks of birth rather than puberty; a reader who treats either as deciding this bill is asking a question the verse was not written to answer.

The case each way

What is the strongest argument for, and against?

The dispute is whether a categorical statutory ban or a regulated clinical pathway is the right way to handle these treatments for people under nineteen.

• For: a bright line at nineteen is easier to follow than case-by-case rules written by one officer.
• For: the telehealth language closes an out-of-state prescribing route that the current section 71-7304 left ambiguous.
• For: $25,000 per violation and Attorney General suits give the ban real force beyond private lawsuits.
• Against: it removes clinical judgment even where a practitioner and the parents agree on treatment.
• Against: per-prescription penalties over a twenty-year window may deter practitioners from any adjacent endocrine care.
• Against: excluding gender dysphoria from "disease" forecloses treatment for the exact condition patients present with.

What is unsettled

What should I be careful about?

This reading comes only from the introduced bill text; a lot of practical effect is left to other law and to rulemaking.

• The text states no fiscal note, appropriation, or cost estimate for Attorney General enforcement.
• No effective date appears; "effective date of this act" is used but never fixed in this text.
• The bill does not say what happens to patients still in treatment after January 1, 2027.
• "Precocious puberty" and "physical injury" are used as exceptions but not defined in 71-7303.
• The chief medical officer must write rules to carry out subsection (2), with the content unspecified.
• Whether the twenty-year enforcement window reaches conduct before enactment is not addressed.

Text (1)

• Introduced (application/pdf)

Each link opens the Legislature's own document. The text itself is not in our database yet (fetched lazily); when it lands these pages will carry it verbatim.

All Actions (10)

Votes (0)

There have been no roll call votes on this bill.

Sponsors (2)

• Sen. Kathleen Kauth [District 31] — primary sponsor
• Sen. Dave Murman [District 38]

Amendments (0)

There are no amendments to this bill.

Fiscal Notes & Statements (3)

• Committee Statement — Committee Statement
• Fiscal Note — Fiscal Note
• Statement of Intent — Statement of Intent

The Legislature's own companion documents; each link opens the official copy.

Committees (1)

Related Bills (0)

No related bill information was received for LB732.